Wood Larry L 4

What Happened

• Larry L. Wood, President, CEO and a director of PROCEPT BioRobotics (PRCT), received equity awards on March 5, 2026 totaling 231,436 shares: 127,783 restricted stock units (RSUs) and 103,653 shares reported as a derivative award (stock option). Both awards were reported with an acquisition price of $0 (typical for grants).

Key Details

• Transaction date: 2026-03-05; Form 4 filed 2026-03-09 (filed within the usual 2-business-day window).
• Award amounts: 127,783 RSUs (F1) and 103,653 derivative shares (stock option, F2); combined = 231,436 shares.
• Acquisition price reported: $0 for both awards (these are grants, not purchases).
• Shares owned after the transaction: not specified in the filing.
• Vesting (from footnotes):
  • RSUs (F1): 25% vest on March 5, 2027; the remaining RSUs vest quarterly thereafter as 1/16th of the remainder each quarter over 36 months, subject to continued service.
  • Stock option/derivative (F2): vests monthly at 1/48th of the optioned shares starting March 5, 2026, over four years, subject to continued employment.

Context

• These are grants (awards), not open-market purchases or sales; they reflect compensation/retention incentives and vest over time contingent on continued service. The derivative award is a standard time‑vesting stock option structure, not an immediate exercise or cashless sale. No additional indicators of insider sentiment (e.g., sales or purchases) are provided in this filing.